Key Highlights
- SK Hynix launched its US ADRs at $149, securing $26.5 billion in capital
- Demand during the offering reached approximately $171.5 billion — exceeding supply by 7x
- Major investors including Coatue, Baillie Gifford, and Situational Awareness signaled interest totaling up to $7 billion
- Barclays launched coverage with Overweight rating and $330 target — suggesting approximately 117% potential gain from $152.35
- Analyst forecasts DRAM demand expansion reaching 35% in 2027 while supply grows only 20%
SK Hynix (SKHY) stock is currently hovering near $186 following its debut on US exchanges last week, after the ADRs were offered at $149 each — and analysts are already weighing in aggressively.
During the bookbuilding process, the offering attracted approximately $171.5 billion in orders. With 177.9 million ADRs available, demand outstripped supply by more than sevenfold. The overwhelming interest meant most participants received allocations significantly below their requests.
Among the prominent investors, three major players — Coatue Management, Baillie Gifford, and Situational Awareness — collectively signaled appetite for as much as $7 billion. The investor roster also featured sovereign wealth funds, technology-focused investment vehicles, and international institutional managers.
The enthusiasm is particularly striking considering market conditions at the time.
Memory chip equities — encompassing both SK Hynix’s Korea-traded shares and Micron — had plunged into bear territory during the days preceding the American listing. Market participants were dumping the semiconductor memory sector amid concerns about a cyclical peak, despite strong quarterly results from competitors. Yet institutional capital was simultaneously flooding toward SK Hynix in enormous volumes.
Barclays Launches Coverage With Bullish $330 Forecast
On Tuesday, Barclays introduced its coverage with an Overweight designation and established a $330 price objective, representing potential appreciation of roughly 117% above Monday’s closing level of $152.35.
Analyst Simon Coles contends that DRAM supply constraints will intensify during 2027, projecting bit supply expansion of approximately 20% annually will substantially lag behind demand acceleration toward 35%. His outlook suggests this supply-demand imbalance will extend across multiple years.
Regarding SK Hynix in particular, Coles anticipates the firm will maintain its dominance in high-bandwidth memory (HBM) technology. He indicated that supposed technical gaps compared to Samsung should be “neutralised by HBM4E,” with SK Hynix preserving an HBM market share exceeding 50% into the foreseeable horizon.
Coles additionally highlighted an evolving investment thesis centered on shareholder distributions. His projections indicate SK Hynix will accumulate cash reserves representing over 40% of its present market capitalization by 2027’s conclusion, creating significant capacity for share repurchases. Under a scenario incorporating a $50 billion buyback initiative, Barclays forecasts double-digit earnings per share expansion in 2028 — even assuming flat or marginally declining average selling prices.
Chinese Competition: Growing but Contained Near-Term
Coles acknowledged that China’s memory manufacturers are making rapid technological strides. The leading Chinese DRAM producer elevated its DDR5 yield above 75% by late 2025, with bit shipment volumes estimated to climb 55% year-over-year during 2025 and 48% throughout 2026.
However, he views the immediate global ramifications as constrained. Any market share captured by Chinese producers outside their domestic market would liberate merely 1-4% of aggregate capacity across Samsung, SK Hynix, and Micron. Furthermore, China’s HBM3 advancement remains behind schedule, with volume production likely postponed until 2027.
The American offering itself generated approximately $26.5 billion according to regulatory disclosures, positioning it among the most substantial public offerings in recent years.
Barclays’ $330 valuation represents the inaugural official Wall Street assessment on the ADRs since trading commenced.
